The Worldwide Industry for Wearable Cardioverter Defibrillators is Expected to Reach Around $1.1 Billion by 2028
15 janv. 2021 08h03 HE
|
Research and Markets
Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Wearable Cardioverter Defibrillator Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The value of global...
Defibrillator Market Forecast Report 2020: Focus on US, Germany, Spain, Italy, France, United Kingdom and Japan
08 janv. 2021 06h38 HE
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Defibrillator - Market Insights, Competitive Landscape and Market Forecast - 2025" report has been added to ResearchAndMarkets.com's offering. This...
Global $10.08 Billion Defibrillators (Implantable Cardioverter & External) Market Opportunity Analysis and Industry Forecast to 2026
14 sept. 2020 06h48 HE
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Defibrillators Market by Type, and External Defibrillators), by End User, by Geography Global Opportunity Analysis and Industry Forecast up to 2026"...
CBRS Alliance Celebrates Availability of OnGo™ Service in 3.5 GHz CBRS Band at Pivotal Launch Event
18 sept. 2019 11h31 HE
|
CBRS Alliance
WASHINGTON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Today, the CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
FCC Authorizes Historic OnGo™ Deployments in 3.5 GHz CBRS Band, Opens Billions in Economic Opportunity for U.S.
16 sept. 2019 11h56 HE
|
CBRS Alliance
SUNNYVALE, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- The CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
US FDA GRANTS PV-10 ORPHAN DRUG DESIGNATION FOR NEUROBLASTOMA
05 nov. 2018 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company was granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA)...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Heart Implant Patients' Fears About Shock Leads to Sexual Dysfunction
14 nov. 2011 10h10 HE
|
American Heart Association
Study Highlights:
Adults with congenital heart disease who have implanted defibrillators often have shock-related anxiety about the device delivering a shock during sex.
The anxiety can...